CMB International Securities: Maintains iFlytek Medical Technology (02506.HK) "Buy" rating with a target price of HK$141.5.

According to the Zhitong Finance APP, CMB International Securities released a research report stating that it maintains a "Buy" investment rating on Xunfei Medical Technology (02506.HK), with a target price of 141.5 Hong Kong dollars for the first time, reflecting a 37.9% potential upside, corresponding to a 2025/26 price-to-sales ratio (P/S) of 14.8 times and 11.2 times.